Titan Securities Ltd (530045)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Titan Securities' net interest income was ₹0.0 Cr (-99.6% year on year, -99.9% on the previous quarter), and net profit ₹4.5 Cr (+63.7% year on year).
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Net interest income | ₹0.0 | -99.6% | -99.9% |
| Operating profit | ₹-0.0 | — | — |
| Net profit | ₹4.5 | +63.7% | +63.1% |
| EPS (₹) | 1.82 | +64.0% | +62.5% |
📢 Recent Corporate Announcements
Titan Securities Limited concluded its 34th Annual General Meeting on September 29, 2026, conducted via video conference with 301 total members present. Ordinary business included adopting FY26 audited financial statements and re-appointing Director Naresh Kumar Singla. Key special business items commended for approval included borrowing powers, creation of charges/mortgages on company properties, and approval of material related party transactions. The company also noted proposed steps toward listing its securities with NSDL.
- Held 34th AGM on September 29, 2026, between 5:00 PM and 5:59 PM IST
- A total of 301 members attended the meeting (4 promoter/promoter group and 297 public via VC)
- Put forward special business resolutions for borrowing powers, creation of charges/mortgages, and material related-party transactions
- Noted plans to pursue steps toward listing securities with NSDL subject to regulatory approvals
Titan Securities has appointed Mr. Ranjeet Kumar as its Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) effective August 13, 2026. Mr. Kumar has over 15 years of experience in accounts, taxation, and financial management. This appointment comes as the company, a micro-cap NBFC with a market cap of ₹106 Cr, manages a unique financial profile where TTM PAT (₹12 Cr) significantly exceeds TTM Revenue (₹6 Cr). The transition is a routine regulatory requirement for filling key leadership roles.
- Appointment of Mr. Ranjeet Kumar as CFO effective from August 13, 2026
- New CFO brings over 15 years of professional experience in accounting and taxation
- Company maintains a high promoter holding of 73.95% as of June 2026
- TTM PAT stands at ₹12 Cr against a TTM Revenue of ₹6 Cr, indicating high non-operating income
- Mr. Kumar holds a B.Com (Honours) degree and has completed CA Intermediate
Titan Securities has appointed Mr. Ranjeet Kumar as Chief Financial Officer (CFO) effective August 13, 2026, following a board meeting to approve Q1 FY27 results. The company reported a consolidated net profit share from its associates, Titan Biotech and Peptech Biosciences, amounting to ₹4.56 Cr for the quarter ended June 30, 2026. This quarterly profit share is highly significant, representing approximately 76% of the company's total TTM revenue of ₹6 Cr. Mr. Kumar brings over 15 years of experience in accounts and taxation to the leadership team.
- Appointment of Mr. Ranjeet Kumar as CFO (KMP) effective August 13, 2026.
- Group share of net profit from associates stood at ₹456.46 lacs (₹4.56 Cr) for Q1 FY27.
- New CFO has 15+ years of experience and is a CA Intermediate with a B.Com (Hons) degree.
- Consolidated results include performance from associates Titan Biotech Limited and Peptech Biosciences Limited.
- The board meeting was brief, commencing at 5:00 P.M. and concluding at 5:30 P.M.
Titan Securities reported its Q1 FY27 results, where the primary driver of performance remains the profit share from its associates, Titan Biotech and Peptech Biosciences, amounting to Rs 4.56 crore. This is significant considering the company's standalone TTM revenue is only Rs 6 crore. Alongside the results, the company appointed Mr. Ranjeet Kumar as the new Chief Financial Officer, bringing 15 years of experience in accounts and taxation. The company maintains a small-cap profile with a market cap of Rs 106 crore and a high promoter holding of 73.95%.
- Group's share of net profit from associates for Q1 FY27 stood at Rs 4.56 crore
- Mr. Ranjeet Kumar appointed as Chief Financial Officer (KMP) effective August 13, 2026
- Consolidated results incorporate performance from two associates: Titan Biotech Ltd and Peptech Biosciences Ltd
- The new CFO holds a B.Com (Hons) and is a CA Intermediate with 15 years of experience
- Board meeting for approval of results and appointment concluded within 30 minutes
Titan Securities has scheduled a board meeting for August 13, 2026, to approve its unaudited financial results for the quarter ended June 30, 2026. This micro-cap NBFC (Market Cap: Rs 105 Cr) has a unique financial profile where TTM PAT of Rs 12 Cr significantly exceeds its TTM Revenue of Rs 6 Cr, suggesting heavy reliance on investment income or other non-operating gains. The trading window for insiders has been closed since June 23, 2026, and will remain so until 48 hours after the results are declared.
- Board meeting scheduled for August 13, 2026, to approve Q1 FY27 results
- Trading window for insiders has been closed since June 23, 2026
- Company reported a TTM PAT of Rs 12 Cr against a TTM Revenue of Rs 6 Cr
- Promoter holding remains stable at 73.95% as of June 2026
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
